A patient’s BMI had no significant impact on adverse outcomes after liver transplantation, according to research presented at ...

Leading global healthcare company Novo Nordisk announces the launch of Wegovy® in Hong Kong, now available at private clinics ...

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...

Unlike diets that focus on restriction or rules, ‘Hara Hachi Bu’ is more of a mindful habit than a regimen. It does not count ...

One in ten children start school obese, NHS warns. Experts say the rise could have a devastating impact on health and widen inequality.

In 2026 patents on semaglutide (the active ingredient in Wegovy and Ozempic) will expire in large emerg­ing markets including ...

GLP-1 drugs like Ozempic are reshaping obesity care, blending real weight loss gains with new questions about safety, access, ...

But according to wellness expert and Dietium.com founder Srasti, our collective reliance on this single number is “not just ...

The figures for childhood obesity of Reception age and Year 6 kids show some areas of the Black Country and Staffordshire ...

According to new survey data from Gallup, for the first time in years, there’s a significant drop in obesity rates. The percentage of obese Americans has apparently dropped from 39.9% in 2022 to 37% ...

In general, people are considered to be at a healthy weight if their BMI is between 18.5 and 24.9. A BMI of 25 or more is considered overweight, while a BMI of 30 or higher is considered obesity.

Mounjaro, the breakthrough obesity and diabetes drug from Eli Lilly and Company, has become India’s highest-selling ...